question 1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Question 1 PowerPoint Presentation
Download Presentation
Question 1

Loading in 2 Seconds...

  share
play fullscreen
1 / 6
derica

Question 1 - PowerPoint PPT Presentation

87 Views
Download Presentation
Question 1
An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Question 1 • For use in drug development what are some important principles for developing algorithms that classify mutational constellations as “drug resistant”? How should mutational algorithms and/or phenotypic breakpoints be developed in the future?

  2. Question 2 • In addition to the covariates and methodology for assessing treatment response included in the DAP what additional covariates or methodologies should be considered when evaluating resistance data?

  3. Question 3 • Do the data presented support the clinical utility of HIV genotypic testing for use in drug development?

  4. Question 4 • Do the data presented support the clinical utility of HIV phenotypic testing for use in drug development?

  5. Question 5 • What are the limitations of the data correlating mutational patterns with clinical outcome?

  6. Question 6 • What additional clinical studies are needed to further define the clinical utility of resistance testing?